{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:59:25Z","timestamp":1773403165895,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-024-03984-7","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T06:22:17Z","timestamp":1733466137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: anti-IgLON5 disease combined with paraneoplastic cerebellar degeneration with the detection of anti-sulfatide IgG antibody, masquerading as meningoencephalitis"],"prefix":"10.1186","volume":"24","author":[{"given":"Si-Dian","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe-Yan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Mei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shui-Sheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"issue":"6","key":"3984_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13(6):575\u201386.","journal-title":"Lancet Neurol"},{"issue":"1","key":"3984_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-022-03044-y","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, Zhang L, Wang Y. Anti-IgLON5 disease complicated with rectal adenocarcinoma: a case report. BMC Neurol. 2023;23(1):1.","journal-title":"BMC Neurol"},{"issue":"18","key":"3984_CR3","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig C, Graus F, Compta Y, H\u00f6gl B, Bataller L, Br\u00fcggemann N, et al. Clinical manifestations of the anti-IgLON5 disease. Neurology. 2017;88(18):1736\u201343.","journal-title":"Neurology"},{"issue":"2","key":"3984_CR4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3233\/JAD-201105","volume":"79","author":"M Tagliapietra","year":"2021","unstructured":"Tagliapietra M, Frasson E, Cardellini D, Mariotto S, Ferrari S, Zanusso G, et al. Hypothalamic-Bulbar MRI Hyperintensity in Anti-IgLON5 Disease with serum-restricted antibodies: a case report and systematic review of literature. J Alzheimers Dis. 2021;79(2):683\u201391.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"3984_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.4103\/1673-5374.355742","volume":"18","author":"YH Zhang","year":"2023","unstructured":"Zhang YH, Ni Y, Gao YN, Shen DD, He L, Yin D, et al. Anti-IgLON5 disease: a novel topic beyond neuroimmunology. Neural Regen Res. 2023;18(5):1017\u201322.","journal-title":"Neural Regen Res"},{"issue":"6","key":"3984_CR6","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.1212\/NXI.0000000000000605","volume":"6","author":"C Gaig","year":"2019","unstructured":"Gaig C, Ercilla G, Daura X, Ezquerra M, Fern\u00e1ndez-Santiago R, Palou E, Sabater L, et al. HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease. Neurol Neuroimmunol Neuroinflamm. 2019;6(6):e605.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"3984_CR7","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/brain\/awac090","volume":"146","author":"T Gr\u00fcter","year":"2023","unstructured":"Gr\u00fcter T, M\u00f6llers FE, Tietz A, Dargvainiene J, Melzer N, Heidbreder A, et al. Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease. Brain. 2023;146(2):600\u201311.","journal-title":"Brain"},{"issue":"5","key":"3984_CR8","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1212\/NXI.0000000000000385","volume":"4","author":"JA Honorat","year":"2017","unstructured":"Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, et al. IgLON5 antibody: neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflamm. 2017;4(5):e385.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"3984_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/01.md.0000076004.64510.ce","volume":"82","author":"I Rojas-Marcos","year":"2003","unstructured":"Rojas-Marcos I, Rousseau A, Keime-Guibert F, Re\u00f1\u00e9 R, Cartalat-Carel S, Delattre JY, et al. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer. Med (Baltim). 2003;82(3):216\u201323.","journal-title":"Med (Baltim)"},{"issue":"1","key":"3984_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ana.20529","volume":"58","author":"SJ Pittock","year":"2005","unstructured":"Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005;58(1):96\u2013107.","journal-title":"Ann Neurol"},{"issue":"5","key":"3984_CR11","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/jog.12331","volume":"40","author":"VA Kumari","year":"2014","unstructured":"Kumari VA, Gupta P, Srivastava MV, Kumar L, Kriplani A, Bhatla N. Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report. J Obstet Gynaecol Res. 2014;40(5):1463\u20135.","journal-title":"J Obstet Gynaecol Res"},{"issue":"6","key":"3984_CR12","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.3747\/co.25.4106","volume":"25","author":"M Le May","year":"2018","unstructured":"Le May M, Dent S. Anti-yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review. Curr Oncol. 2018;25(6):e585\u201391.","journal-title":"Curr Oncol"},{"issue":"2","key":"3984_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12311-015-0664-x","volume":"15","author":"H Mitoma","year":"2016","unstructured":"Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, et al. Consensus Paper: Neuroimmune mechanisms of Cerebellar Ataxias. Cerebellum. 2016;15(2):213\u201332.","journal-title":"Cerebellum"},{"issue":"2","key":"3984_CR14","first-page":"89","volume":"48","author":"HZ Guan","year":"2018","unstructured":"Guan HZ, Ren HT, Peng B, Ni J, Li LB, Lu Q, et al. Anti-yo antibody-associated paraneoplastic cerebellar degeneration: a report of 6 patients. Chin J Neurol. 2018;48(2):89\u201393.","journal-title":"Chin J Neurol"},{"key":"3984_CR15","doi-asserted-by":"publisher","first-page":"106992","DOI":"10.1016\/j.parkreldis.2024.106992","volume":"124","author":"Y Ono","year":"2024","unstructured":"Ono Y, Tadokoro K, Yunoki T, Yamashita T, Sato D, Sato H, et al. Anti-IgLON5 disease as a differential diagnosis of multiple system atrophy. Parkinsonism Relat Disord. 2024;124:106992.","journal-title":"Parkinsonism Relat Disord"},{"key":"3984_CR16","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.3389\/fimmu.2018.02708","volume":"9","author":"S Macher","year":"2018","unstructured":"Macher S, Zimprich F, De Simoni D, H\u00f6ftberger R, Rommer PS. Management of Autoimmune Encephalitis: an Observational Monocentric Study of 38 patients. Front Immunol. 2018;9:2708.","journal-title":"Front Immunol"},{"key":"3984_CR17","doi-asserted-by":"publisher","first-page":"753856","DOI":"10.3389\/fimmu.2021.753856","volume":"12","author":"S Macher","year":"2021","unstructured":"Macher S, Milenkovic I, Zrzavy T, H\u00f6ftberger R, Seidel S, Berger-Sieczkowski E, et al. Ocular Motor abnormalities in Anti-IgLON5 Disease. Front Immunol. 2021;12:753856.","journal-title":"Front Immunol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03984-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03984-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03984-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T07:03:29Z","timestamp":1733468609000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03984-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3984"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03984-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of the Guangdong Sanjiu Brain Hosptial approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"476"}}